Lymphoma - Featured Clinical Trials
The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:
- Targeted Therapy for Mantle Cell Lymphoma
(Posted: 01/10/2006) - In this trial, researchers will treat mantle cell lymphoma patients with a drug called bortezomib, followed by induction therapy with bortezomib and a chemotherapy combination known as DA-EPOCH-R, along with the drug filgrastim to stimulate white blood cell production. Half of the patients will subsequently receive bortezomib maintenance therapy.
- Chemotherapy for Recurrent or Treatment-Resistant Lymphomas
(Posted: 07/26/2005) - In this trial, researchers are trying to determine whether a new drug called UCN-01 will help kill cancer cells in patients who have a type of lymphoma called anaplastic large cell lymphoma.
- Preventing Graft-versus-Host Disease during Hematologic Cancer Treatment
(Posted: 05/31/2005) - Researchers are investigating whether an immunosuppressive drug, sirolimus, can work with cyclosporine to prevent graft-versus-host disease (GVHD) more effectively than cyclosporine alone following allogeneic hematopoietic stem cell transplantation.
- Improving Allogeneic Stem Cell Transplantation
(Posted: 02/22/2005) - In this study, researchers are testing whether a modified transplantation regimen may reduce complications while preserving the benefits of haploidentical allogeneic stem cell transplantation.
- Study of Individuals and Families at High Risk for Blood Cancers
(Posted: 07/27/2004) - Researchers want to study individuals and families who may have a genetic predisposition to developing hematologic cancers. Studying this population may help identify other persons at risk, precursor conditions, clues to etiology, and the genes involved in these malignancies.